FC2ブログ

Blog

Intro

Publication

Conference

ZF Protocol

Link

Publication

  • 2016/01/05
  • 15:40
Publication List (English)
Asterisk: corresponding author
Red: first author
Underbar is Me!
2025
91. Kon T, Kon-Nanjo K, Handayani KS, Zang L, Fahrurrozi, Simakov O, Gultom VDN, Shimada Y*. Chromosome-level genome assembly of the doctor fish (Garra rufa). bioRxiv. 2025. doi: https://doi.org/10.1101/2025.03.11.642249

90. Shimada Y*, Aydın B, Kon-Nanjo K, Handayani KS, Gultom VDN, Simakov O, Fahrurrozi, Kon T. Potential of Garra rufa as a Novel High-Temperature Resistant Model Fish: A Review on Current and Future Approaches. Zoological Lett. 2025;11:3.

2024
89. Bhavsar PS, Solanki M, Shimada Y, Kamble SB, Patole SP, Gore AH*. Microplastic Contamination in Indian Rice: A Comprehensive Characterization and Health Risk Assessment. J Hazard Mater. 2024;136208.

88. Bhagat J, Singh N, Shimada Y*.  Ecotoxicology and Risk Assessment of Contaminated Water. Emersing Comtaminants and Associated Treatment Technologies. Contaminated Land and Water: Remediation and Management. Springer. 2024; 1-14.

87. Oda K, Katayama K*, Zang L, Toda M, Tanoue A, Saiki R, Yasuma T, Gabazza C, Shimada Y, Mori M, Suzuki Y, Murata T, Hirai T, Tryggvason K, Gabazza E, Dohi K. The Protective Role of KANK1 in Podocyte Injury. Int J Mol Sci. 2024;25:5805.

86. Zang L*, Saitoh S, Katayama K, Zhou W, Nishimura N, Shimada Y. A Zebrafish Model of Diabetic Nephropathy shows Hyperglycemia, Proteinuria and Activation of the PI3K/Akt Pathway. Dis Model Mech. 2024;17, dmm050438.

85. Shimada Y*, Zang L, Ishimaru T, Nishiura K, Matsuda K, Uchida R, Nakayama H, Matsuoka I, Terasawa M, Nishimura N. Lipid- and Glucose-lowering Effects of Rhamnan Sulphate from Monostroma nitidum with altered Gut Microbiota in Mice. Food Sci Nutr. 2024;12:4342-4352.


2023

82. Terasawa M, Zang L, Hiramoto K, Shimada Y, Mitsunaka M, Uchida R, Nishiura K, Matsuda K, Nishimura N, Suzuki K*. Oral administration of rhamnan sulfate from Monostroma nitidum suppressed atherosclerosis in ApoE-deficient mice fed a high-fat diet. Cells. 2023;12:2666.

81. Bhavsar PS, Dongare PR, Shimada Y, Gore AH*. A critical review on current challenges in analysis of microplastics (MPs) in food samples. ACS Food Sci Techonol. 2023;3:2001-2017.

80. Zang L*, Baharlooeian M, Terasawa M, Shimada Y, Nishimura N. Beneficial Effects of Seaweed-derived Components on Metabolic Syndrome via Gut Microbiota Modulation. Front Nutr. 2023;10:1173225.

79. Yoshizawa K, Matsura A, Shimada M, Ishihara IS, Sato F, Yamamoto T, Yaguchi K, Kawamoto E, Kuroda T, Matsuo K, Tamaoki N, Shimada Y, Mishra M, Uehara R*. Tetraploidy-linked sensitization to CENP-E inhibition in human cells. Mol Oncol. 2023;17:1148-1166.

78. Ichikawa S, Abe R, Fujimoto H, Higashi K, Zang L, Nakayama H, Matsuoka I, Shimada Y*. Paraburkholderia sabiae administration alters zebrafish anxiety-like behavior via gut microbial taurine metabolism. Front Microbiol. 2023;14:1079187.

2022
77. Ichii S, Matsuoka I, Okazaki F, Shimada. Y*. Zebrafish models for skeletal muscle senescence: lessons from culture cells and rodent models. Molecules. 2022;27:8625.

76. Bhagat J, Zang L, Nishimura N, Shimada Y*. Application of omics approaches for assessing microplastic and nanoplastic toxicity in fish and seafood species.  TRAC-Trend Anal Chem. 2022;154:116674.

75. Bhagat J, Zang L, Kaneco S, Nishimura N, Shimada Y*. Combined exposure to nanoplastics and metal oxide nanoparticles inhibits efflux pumps and causes oxidative stress in zebrafish embryos. Sci Total Environ. 2022;835:155436.

74. Zang L*, Nishimura N, Torraca V, Shimada Y. Zebrafish Models for Human Disease Studies. Frontiers Media SA. 2022. doi: 10.3389/978-2-88974-832-7 [e-Book]

73. Zang L*, Torraca V, Shimada Y, Nishimura N. Editorial: Zebrafish Models for Human Disease Studies: Front Cell Dev Biol. 2022;10:861941.

72. Matsuoka I, Hata K, Katsuzaki H, Zang L, Ota M, Kim Y, Chu D, Juneja L, Nishimura N, Shimada Y*. Zebrafish obesogenic test identifies anti-adipogenic fraction in Moringa oreifera leaf extracts. Food Sci Nurt. 2022;00:1-9.

71. Zang L*, Shimada Y, Miyake H, Nishimura N. Transcriptome Analysis of Molecular Response to UVC Irradiation in Zebrafish Embryos. Ecotox Environ Safe. 2022;231:113211.

2021
70.  Zang L*, Shimada Y, Nakayama H, Matsuoka I, Kim Y, Chu D, Juneja LR, Tsuruta R, Sasakawa Y, Kuroyanagi J, Nishimura N. Globin digest improves visceral adiposity through UCP1 upregulation in diet-induced obese zebrafish and mice. Front Nurt. 2021;8:650975.

69.  Bhagat J, Zang L, Nakayama H, Nishimura N, Shimada Y*. Effects of nanoplastic on toxicity of azole fungicides (ketoconazole and fluconazole) in zebrafish embryos. Sci Total Environ. 2021;800:149463.

68.  Shimada Y*, Terasawa M, Okazaki F, Nakayama H, Zang L, Nishiura K, Matsuda K, Nishimura N. Rhamnan sulphate from green algae Monostroma nitidum improves constipation with gut microbiome alteration in double-blind placebo-controlled trial. Sci Rep. 2021;11:13384.

67. Baharlooeian M, Kerdgari M*, Shimada Y. Ecotoxicological effects of TiO2 nanoparticulates and bulk Ti on microalgae Chaetoceros muelleri. Environ Technol Innov. 2021;23:101720

66. Nishimura M, Fuchino H, Takayanagi K, Kawakami H, Nakayama N, Kawahara N, Shimada Y*. Toxicity of jegosaponins A and B from Styrax japonica Siebold et al. Zuccarini in prostate cancer cells and zebrafish embryos resulting from increased membrane permeability. Int J Mol Sci. 2021;22,6354.

65. Zang L*, Shimada Y, Nakayama H, Kim Y, Chu D, Juneja LR, Kuroyanagi J, Nishimura N. Preventive Effects of green tea extract against obesity development in zebrafish. Molecules. 2021;26:2627.

64. Bhagat J, Nishimura N, Shimada Y*. Worming into a robust model to unravel the micro/nanoplastic toxicity in soil: A review on Caenorhabditis elegans. TRAC-Trend Anal Chem. 2021;138:116235. - Corresponding author.

63. Zang L, Kagotani K, Nakayama H, Bhagat J, Fujimoto Y, Hayashi A, Sono R, Katsuzaki H, Nishimura N, Shimada Y*. 10-Gingerol Suppresses Osteoclastogenesis in RAW264.7 Cells and Zebrafish Osteoporotic Scales. Front Cell Dev Biol. 2021;9:588093. -  Corresponding author.

2020
62. Nakayama H, Hata K, Matsuoka I, Zang L, Kim Y, Chu D, Juneja LR, Nishimura N, Shimada Y*. Anti-obesity natural products tested in juvenile zebrafish obesogenic tests and mouse 3T3-L1 adipogenesis assays. Molecules. 2020; 25:5840. - Equally contributed first and corresponding author.


60. Bhagat J, Singh N, Nishimura N, Shimada Y*. A comprehensive review on environmental toxicity of azole compounds to fish. Chemosphere. 2020; 262:128335. - Corresponding author.

59. Bhagat J, Nishimura N, Shimada Y*. Toxicological interactions of microplastics / nanoplastics and environmental contaminants: Current Knowledge and Future Perspectives. J Hazard Mater. 2021;405:123913. - Corresponding author.

58. Shimada Y*, Hazekawa M. Developing a model for a siRNA delivery system by cancer implantation into zebrafish circulation. Methods Mol Biol. 2021; 2174:263-275. - First and corresponding author.

57. Matsuura N, Zang L, Nishimura N, Shimada Y*. Lacto-fermented Cauliflower fungus (Sparassis crispa) ameliorates hepatic steatosis by activating beta-oxidation in a diet-induced obese zebrafish. J Med Food. 2020;23:803-810.- Corresponding author.

56. Bhagat J, Zang L, Nishimura N, Shimada Y*. Zebrafish: An emerging model to study microplastic and nanoplastic toxicity. Sci Total Environ. 2020;728:138707. - Corresponding author.

55. Chensom S, Shimada Y, Nakayama H, Yoshida K, Kondo T, Katsuzaki H, Hasegawa S and Mishima T*. Determination of anthocyanins and antioxidants in ‘Titanbicus’ edible flowers in vitro and in vivo. Plant Food Hum Nutr. 2020;75:265-271.

54. Kagotani K, Nakayama H, Zang L, Fujimoto Y, Hayashi A, Sono R, Nishimura N, Shimada Y*. Lecithin-based dermal drug delivery for anti-pigmentation maize ceramide. Molecules. 2020;25:1595. - Equally contributed first and corresponding author.

53. Yamada Y, Chensom S, Yonemoto H, Nakayama H, Zang L, Nishimura N, Mishima T, Shimada Y*. Water extract of Yamato-Tachibana (Citrus tachibana) induces food intake in adult and larval zebrafish. J Med Food. 2020;23:65-71. - Corresponding author.

2019
52. Sawaki R, Sato D, Nakayama H, Nakagawa Y, Shimada Y*. ZF-AutoML: An easy machine learning-based method to detect anomalies in fluorescent-labelled zebrafish. Inventions. 2019;4:72. - Corresponding author.


50. Zang L*, Shimada Y, Nakayama H, Kim Y, Chu D, Juneja LR, Kuroyanagi J, Nishimura N. RNA-seq based transcriptome analysis of the anti-obesity effect of green tea extract using zebrafish obesity models. Molecules. 2019;24:3256.

49. Monma Y, Shimada Y, Nakayama H, Zang L, Nishimura N, Tanaka T*. Aging-associated microstructural deterioration of vertebra in zebrafish. Bone Rep. 2019;11:100215.- Equally contributed first author.

48. Zang L*, Shimada Y, Nakayama H, Chen W, Okamoto A, Koide H, Oku N, Dewa T, Shiota M, Nishimura N. Therapeutic silencing of centromere protein X ameliorates hyperglycemia in zebrafish and mouse models of type 2 diabetes mellitus. Front Genet. 2019;10:693.

47. Kawada T, Kuroyanagi J, Okazaki F, Taniguchi T, Nakayama H, Suda N, Abiko S, Kaneco S, Nishimura N, Shimada Y*. An integrative evaluation method for the biological safety of down and feather materials. Int J Mol Sci. 2019;20:1434. - Corresponding author.

46. Vranic S, Shimada Y, Ichihara S*, Kimata M, Wu W, Tanaka T, Boland S, Tran L, Ichihara G. Toxicological evaluation of SiO2 nanoparticles by zebrafish embryo toxicity test. Int J Mol Sci. 2019;20:882. - Equally contributed first author.

45. Yamamoto D, Sato D, Nakayama H, Nakagawa Y, Shimada Y*. ZF-Mapper: Simple and complete freeware for fluorescence quantification in zebrafish images. Zebrafish. 2019;16:233-239. - Corresponding author.

44. Okazaki F, Zang L, Nakayama H, Chen Z, Gao Z, Chiba H, Hui S, Aoki T, Nishimura N, Shimada Y*. Microbiome alteration in Type 2 Diabetes Mellitus model of zebrafish. Sci Rep. 2019;9:867. - Equally contributed first and corresponding author.

2018
43. Nakayama H, Shimada Y*, Zang L, Terasawa M, Nishiura K, Matsuda K, Toombs C,  Langdon C, Nishimura N. A novel anti-obesity properties of Palmaria mollis in zebrafish and mouse models. Nutrients. 2018;10:1401. - Equally contributed first and corresponding author.

42. Chen Z, Wu Y, Zang L, Shimada Y, Nakayama H, Rojeet S, Zhao Y, Miura Y, Nishimura N, Chiba H, Hui S*. Lipidomic profiling on oxidized phospholipids in Type 2 Diabetes Mellitus model zebrafish. Anal Sci. 2018;34:1201-1208.

41. Yang J, Meng Z, Liu Q, Shimada Y, Olsthoorn RC, Spaink HP, Herrmann A, Kros A*. Performing DNA nanotechnology operations on a zebrafish. Chem Sci. 2018;9:7271-7276.

40. Nakayama H, Katayama K, Onabe Y, Sato A, Nishimura N, Shimada Y*. Dried Rotifer Sheet: A Novel Live Feed for Rearing First-Feeding Larvae. Zebrafish. 2018;15:291-294. - Equally contributed first and corresponding author.

2017
39. Zang L*, Shimada Y, Nishimura N. Development of a Novel Zebrafish Model for Type 2 Diabetes Mellitus. Sci Rep. 2017;7:1461. - Equally contributed first author.

38. Ashikawa Y, Nishimura Y, Okabe S, Sato Y, Yuge M, Tada T, Miyao H, Murakami S, Kawaguchi K, Sasagawa S, Shimada Y, Tanaka T*.Protective function of the sterol regulatory element binding factor 1–fatty acid desaturase 1/2 axis in early-stage age-related macular degeneration. Heliyon. 2017;3:3.

2016
37. Yang J, Shimada Y*, Olsthoorn RC, Snaar-Jagalska BE, Spaink HP, Kros A*. Application of Coiled Coil Peptides in Liposomal Anti-Cancer Drug Delivery Using a Zebrafish Xenograft Model. ACS Nano. 2016;10:7428-7435. - Equally contributed first and corresponding author.

36. Inoue A, Nishimura Y, Matsumoto N, Umemoto N, Shimada Y, Maruyama T, Kayasuga K, Morihara M, Katagi J, Shiroya T, Hirota Y, Kim S, Tanaka T*. Comparative study of the zebrafish embryonic toxicity test and mouse embryonic stem cell test to screen developmental toxicity of human pharmaceutical drugs. Fundam. Toxicol. Sci. 2016;3:79-87.

35. Zhang B, Shimada Y, Hirota T, Ariyoshi M, Kuroyanagi J, Nishimura Y, Tanaka T*. Novel immunologic tolerance of human cancer cell xenotransplants in zebrafish. Transl Res. 2016;170:89-98 - Equally contributed first author.

2015
34. Nishimura Y, Sasagwa S, Ariyoshi M, Ichikawa S, Shimada Y, Kawaguchi K, Kawase R, Yamamoto R, Uehara T, Yanai T, Takata R, Tanaka T*. Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity. Front Pharmacol. 2015;6:19

33. Zang L*, Shimada Y, Nishimura Y, Tanaka T, Nishimura N. Repeated Blood Collection for Blood Tests in Adult Zebrafish. J Vis Exp. 2015;102:e53272.


31. Shimada Y, Kuninaga S, Ariyoshi M, Zhang B, Shiina Y, Takahashi Y, Umemoto N, Nishimura Y, Enari H, Tanaka T*. E2F8 promotes hepatic steatosis through FABP3 expression in diet-induced obesity in zebrafish. Nutr Metab. 2015;12:17.

30. Zhang B, Shimada Y, Kuroyanagi J, Ariyoshi M, Nomoto T, Shintou T, Umemoto N, Nishimura Y, Miyazaki T, Tanaka T*. In vivo selective imaging and inhibition of leukemia stem-like cells using the fluorescent carbocyanine derivative, DiOC5(3). Biomaterials. 2015;52:14-25. - Equally contributed first author.

29. Kawabata M, Umemoto N, Shimada Y, Nishimura Y, Zhang B, Kuroyanagi J, Miyabe M, Tanaka T*. Downregulation of stanniocalcin 1 is responsible for sorafenib-induced cardiotoxicity. Toxicol Sci. 2015;143:374-384.

28. Chang J, Ichihara G, Shimada Y, Tada-Oikawa S, Kuroyanagi J, Zhang B, Suzuki Y, Sehsah R, Kato M, Tanaka T, Ichihara S*. Copper Oxide Nanoparticles Reduce Vasculogenesis in Transgenic Zebrafish Through Down-Regulation of Vascular Endothelial Growth Factor Expression and Induction of Apoptosis. J Nanosci Nanotechnol. 2015;15:2140-2147.

2014
27. Zhang B, Shimada Y, Kuroyanagi J, Nishimura Y, Umemoto N, Nomoto T, Shintou T, Miyazaki T, Tanaka T*. Zebrafish xenotransplantation model for cancer stem-like cell study and high-throughput screening of inhibitors. Tumour Biol. 2014;35:11861-11869.

26. Zang L*, Shimada Y, Kawajiria J, Tanaka T, Nishimura N. Effects of Yuzu (Citrus junos Siebold ex Tanaka) peel on the diet-induced obesity in a zebrafish model. J Funct Foods. 2014;10:499-510.

25. Kuroyanagi J, Shimada Y, Zhang B, Ariyoshi M, Umemoto N, Nishimura Y, Tanaka T*. Zinc finger MYND-type containing 8 promotes tumour angiogenesis via induction of vascular endothelial growth factor-A expression. FEBS Lett. 2014;588:3409-3016. - Equally contributed first author.

24. Nishimura Y, Murakami S, Ashikawa Y, Sasagawa S, Umemoto N, Shimada Y, Tanaka T*. Zebrafish as a systems toxicology model for developmental neurotoxicity testing. Congenit Anom (Kyoto). 2015;55:1-16.

23. Shimada Y, Nishimura Y, Tanaka T*. Zebrafish-based systems pharmacology of cancer metastasis. Methods Mol Biol. 2014;1165: 223-238.

22. Zhang B, Shimada Y, Kuroyanagi J, Umemoto N, Nishimura Y, Tanaka T*. Quantitative phenotyping-based in vivo chemical screening in a zebrafish model of leukemia stem cell xenotransplantation. PLoS One. 2014;9:e85439.

21. Hiramitsu M, Shimada Y, Kuroyanagi J, Inoue T, Katagiri T, Zang L, Nishimura Y, Nishimura N, Tanaka T*. Eriocitrin ameliorates diet-induced hepatic steatosis with activation of mitochondrial biogenesis. Sci Rep. 2014;4:3708. - Equally contributed first author.

2013
20. Shimada Y, Kuroyanagi J, Zhang B, Ariyoshi M, Umemoto N, Nishimura Y, Tanaka T*. Downregulation of max dimerization protein 3 is involved in decreased visceral adipose tissue by inhibiting adipocyte differentiation in zebrafish and mice. Int J Obes. 2013;38:1053-1060.

19. Umemoto N, Nishimura Y, Shimada Y, Yamanaka Y, Kishi S, Ito S, Okamori K, Nakamura Y, Kuroyanagi J, Zhang Z, Zang L, Wang Z, Nishimura N, Tanaka T*. Fluorescent-Based Methods for Gene Knockdown and Functional Cardiac Imaging in Zebrafish. Mol Biotechnol. 2013;55:131-142.

18. Zang L*, Shimada Y, Nishimura Y, Tanaka T, Nishimura N. A Novel, Reliable Method for Repeated Blood Collection from Aquarium Fish. Zebrafish. 2013;10:425-432.

17. Nishimura Y, Yata K, Nomoto T, Ogiwara T, Watanabe K, Shintou T, Tsuboyama A, Okano M, Umemoto N, Zhang Z, Kawabata M, Zhang B, Kuroyanagi J, Shimada Y, Miyazaki T, Imamura T, Tomimoto H, Tanaka T*. Identification of a novel indoline derivative for in vivo fluorescent imaging of blood-brain barrier disruption in animal models. ACS Chem Neurosci. 2013;4:1183-1193.

2012
16. Shimada Y, Hirano M, Nishimura Y, Tanaka T*. A High-Throughput Fluorescence-Based Assay System for Appetite-Regulating Gene and Drug Screening. PLoS One. 2012;7:e52549.

15. Watanabe K, Nishimura Y, Nomoto T, Umemoto N, Zhang Z, Zhang B, Kuroyanagi J, Shimada Y, Shintou T, Okano M, Miyazaki T, Imamura T, Tanaka T*. In vivo assessment of the permeability of the blood-brain barrier and blood-retinal barrier to fluorescent indoline derivatives in zebrafish. BMC Neurosci. 2012;13:101.

14. Hasumura T, Shimada Y, Kuroyanagi J, Nishimura Y, Meguro S, Takema Y, Tanaka T*. Green tea extract suppresses adiposity and affects the expression of lipid metabolism genes in diet-induced obese zebrafish. Nutr Metab. 2012;9:73.

2011
13. Zang L*, Morikane D, Shimada Y, Tanaka T, Nishimura N. A novel protocol for the oral administration of test chemicals to adult zebrafish. Zebrafish. 2011;8:203-220.

12. Tainaka T, Shimada Y, Kuroyanagi J, Zang L, Oka T, Nishimura Y, Nishimura N, Tanaka T*. Transcriptome analysis of anti-fatty liver action by Campari tomato using a zebrafish diet-induced obesity model. Nutr Metab. 2011;8:88. - Equally contributed first author.

11. Oka T, Nishimura Y, Zang L, Hirano M, Shimada Y, Wang Z, Umemoto N, Kuroyanagi J, Nishimura N, Tanaka T*. Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiol. 2010;10:21.

10. Watanabe K, Nishimura Y, Oka T, Nomoto T, Kon T, Shintou T, Hirano M, Shimada Y, Umemoto N, Kuroyanagi J, Wang Z, Zhang Z, Nishimura N, Miyazaki T, Imamura T, Tanaka T*. In vivo imaging of zebrafish retinal cells using fluorescent coumarin derivatives. BMC Neurosci. 2010;11:116.

9. Shimada Y, Tsunoda H, Zang L, Hirano M, Oka T and Tanaka T*. Synergistic induction of heme oxygenase-1 by nicaraven after subarachnoid hemorrhage to prevent delayed cerebral vasospasm. Eur J Pharmacol. 2009;620:16-20.

8. Wang Z, Nishimura Y, Shimada Y, Umemoto N, Hirano M, Zang L, Oka T, Sakamoto C, Kuroyanagi J and Tanaka T*. Zebrafish beta-adrenergic receptor mRNA expression and control of pigmentation. Gene. 2009;446:18-27.

7. Tanaka T*, Oka T, Shimada Y, Umemoto N, Kuroyanagi J, Sakamoto C, Zang L, WangZ, Nishimura Y. Pharmacogenomics of cardiovascular pharmacology: pharmacogenomic network of cardiovascular disease models. J Pharmacol Sci. 2008;107:8-14.

6. Ito Y, Hirano M, Umemoto N, Zang L, Wang Z, Oka T, Shimada Y, Nishimura Y, Kurokawa I, Mizutani H, Tanaka T*. Guinea pig cysteinyl leukotriene receptor 2 (gpCysLT2) mediates cell proliferation and intracellular calcium mobilization by LTC4 and LTD4. BMB Rep. 2008;41:139-145.

5. Matsumoto T, Komori T, Yamamoto M, Shimada Y, Nakagawa M, Shiroyama T, Inui K, Okazaki Y*. Prior intraperitoneal injection of rat recombinant IL-6 increases hypothalamic IL-6 contents in subsequent forced swim stressor in rats. Neuropsychobiology. 2006;54:186-194.

4. Hirano M, Zang L, Oka T, Ito Y, Shimada Y, Nishimura Y, Tanaka T*. Novel reciprocal regulation of cAMP signaling and apoptosis by orphan G-protein-coupled receptor GPRC5A gene expression. Biochem Biophys Res Commun. 2006;351:185-191.

3. Ogasawara M, Satoh N, Shimada Y, Wang Z, Tanaka T, Noji S*. Rapid and stable buffer exchange system using InSitu Chip suitable for multicolor and large-scale whole-mount analyses. Dev Genes Evol. 2006;216:100-104.

2. Masunaga R, Nagasaka A, Sawai Y, Hayakawa N, Nakai A, Hotta K, Kato Y, Hishida H, Takahashi H, Naka M, Shimada Y, Tanaka T, Hidaka H, Itoh M*. Changes in cyclic nucleotide phosphodiesterase activity and calmodulin concentration in heart muscle of cardiomyopathic hamsters. J Mol Cell Cardiol. 2004;37:767-774.

1. Hayashi M, Shimada Y, Nishimura Y, Hama T, Tanaka T*. Genomic organization, chromosomal localization, and alternative splicing of the human phosphodiesterase 8B gene. Biochem Biophys Res Commun. 2002;297:1253-1258

Publication List (Japanese) 
25. 臧 黎清, 島田 康人
糖尿病性腎症の新規治療法開発のための強力なツール ― ゼブラフィッシュモデルの構築
アグリバイオ 2025, Vol. 9, No. 3, p50-52.

24. 市川 俊輔, 島田 康人
魚で腸内細菌はなにをしているの？
Microbiome Science 2024, Vol.3, No.3, p49-50.

23. 島田 康人
骨粗鬆症が予防できる可能性あり！ショウガの皮に骨の破壊を防ぐ成分を発見
ショウガ活用大全（マキノ出版ムック）2022, 11/24.

22. 中山 寛子、相馬 明弘、坂上 実、Nguyen Thanh Thao、松岡 いづみ、西村 訓弘、島田 康人
三重県産天然物を用いた薬湯開発におけるゼブラフィッシュ生体安全性評価
温泉科学 2022, 72巻, p60-73.

21. 臧 黎清、島田 康人、西村訓弘
ゼブラフィッシュ創薬：グロビンペプチドは内臓脂肪のUCP1発現増加を介して肥満を改善する
Bio Clinica 2022, 37巻, 12号, p63-65.

20. 臧 黎清、島田 康人
「治未病」に効く緑茶抽出物 - 肥満ゼブラフィッシュで解明
アグリバイオ 2022, 6巻, 7号, p81-83.

19. 松浦 信男、松下 彬子、臧 黎清、西村 訓弘、島田 康人
乳酸発酵ハナビラタケによる脂肪肝改善作用
日本未病システム学会雑誌2022, 27巻, 3号; 77-80.

18. 島田 康人
ショウガの皮に骨の破壊を防ぐ成分を発見
安心. 2022: 4; 114-115.

17. 臧 黎清、島田 康人、西村 訓弘
グロビン蛋白分解物はUCP1発現増加を誘導し内臓脂肪型肥満を改善する
Precision Medicine. 2021: 4(13); 1275-1277.

16. 臧 黎清、島田 康人、西村 訓弘
ゼブラフィッシュを用いた天然物創薬：グロビン蛋白分解物の抗肥満作用の発見
Medical Science Digest. 2021: 47(11); p596-598.

15. 中山 寛子、島田 康人
「ベーコン風味の機能性食材，紅藻類ダルス」
『代替プロテインによる食品素材開発』～植物肉・昆虫食・藻類利用食・培養肉が導く食のイノベーション～ 第4編　藻類利用食/第2章 藻類による新規機能性食品開発/第2節, p219-225

14. 臧 黎清、中山 寛子.
ゼブラフィッシュを用いた緑茶抽出物の抗肥満作用メカニズムの解明. アグリバイオ2020, 4巻, 13号, p1186-1188.

13. 松岡 いづみ、幡 佳苗、臧 黎清、島田 康人、中山 寛子、金 英一、朱 政治、ジュネジャレカ、西村 訓弘、島田 康人
ゼブラフィッシュ稚魚を用いた抗肥満スクリーニング技術の開発
日本未病システム学会雑誌2020, 26巻, 3号; 74-77

12. 臧 黎清、島田 康人、中山 寛子、西村 訓弘
2型糖尿病モデル動物におけるCENPX遺伝子発現抑制による血糖低下作用
日本未病システム学会雑誌2020, 22巻, 2号; 65-68.【最優秀論文賞】

11. 島田康人
悪性腫瘍モデルゼブラフィッシュを利用した創薬研究
生体の科学2018、69巻、4号、p365-370

10. 臧黎清、島田康人、西村訓弘
食餌性肥満ゼブラフィッシュを用いた天然由来抗肥満成分の探索研究
日本未病システム学会雑誌2016、22巻、2号、p62-66

9. 田中利男、西村有平、島田康人
オミックス創薬科学とターゲットバリデーション
臨床薬理 2011 42巻、p169-170 

8. 黒柳淳哉、島田康人、西村有平、田中利男
新しいヒト癌移植モデルにおける腫瘍血管新生の薬理ゲノミクス研究 
血管 2011、34巻、3号、p123-128 

7. 田中利男，西村有平、島田康人 
新しい生活習慣病モデル動物と薬理ゲノミクス機構 
比較内分泌学 2010、36巻、136号、p38-43 

6. 田中利男、西村有平、島田康人 
薬理ゲノミクスネットワーク解析による次世代創薬科学 
遺伝子医学MOOK 2009、14号、次世代創薬テクノロジ　実践：インシリコ創薬の最前線、第3章
14号, p186-190 

5. 田中利男、西村有平、島田康人、岡　岳彦 
運動と生活習慣病の新しい薬理ゲノミクスネットワーク解析 
臨床スポーツ医学 2008、25巻、10号、p1125-1131 

4. 田中利男、岡岳彦、平野稔、臧黎清、伊藤芳幸、島田康人 
血管リモデリングのゲノム創薬科学 
日本臨床 2006、64巻、5号、p576～582
 

3. 田中利男、島田康人、伊藤芳幸 
血管障害の薬理ゲノミクス/インフォマティクス 
THERAPEUTIC RESEARCH 2006、27巻、1号、p51～57 

2. 島田康人、西村有平、田中利男 
第５章カルシウムシグナリングと細胞機能 
生物薬科学実験講座７情報伝達物質Ⅱ 2005、廣川書店、p445～463 

1. 島田康人、田中利男　 
抗精神病薬の薬理ゲノミクス　 
CLINICAL NEUROSCIENCE 2002、20巻、p738-739

MISC
  1. 2025/3/24 プレスリリース「三重県の未利用資源（新姫搾りかす・オリーブ葉）を活用した抗不安研究で新たな可能性を開拓 ―三重大学とロート製薬の共同研究―」
  2. 2024/12/17 日本テレビ カズレーザーと学ぶ。「食べてキレイになる！冬の鍋の最新科学」にて、これまでのヒトエグサ（アオサ）由来のラムナン硫酸の研究が紹介
Patent List (Japan) 
  1. 特開2025-018809 内臓脂肪蓄積抑制剤およびＡＫＴ活性化・ＡＣＣ活性調節剤
  2. 特開2024-017227 神経突起伸長促進剤およびその製造方法
  3. 特開2023-048160 破骨細胞分化抑制、筋肉量増加、運動機能改善、及び／又は筋力増強用組成物
  4. 特開2021-191257 便秘解消組成物
  5. 特開2021-177705 骨代謝改善組成物およびその製造方法
  6. 特開2016-204361 グアイアズレン誘導体、がん細胞阻害薬及び前立腺がん細胞阻害薬
  7. 特開2016-021947 イメージング用小魚管理装置及びそれに用いられる小魚用イメージングプレート 
  8. 特開2015-151366 養殖魚類、畜産動物、ペット動物の内臓脂肪蓄積を抑制する素材、及び該素材を用いた動物用飼料
  9. 特開2014－169951 小魚類イメージング装置用の小魚類配列装置
  10. 特開2014－101359 がん細胞阻害薬、がん幹細胞検出用プローブ
  11. 特開2014－101358 がん細胞阻害薬、がん幹細胞検出用プローブ
  12. 特開2014－100139 異種細胞移植モデル動物の作製方法
  13. 特開2014－083008 透明ゼブラフィッシュの作製方法、及び当該方法によって作製されたゼブラフィッシュを用いた生体イメージング評価法
  14. 特開2012－184217 中枢神経移行性評価用プローブ、中枢神経移行性評価方法、及び、中枢神経移行性評価用プローブを用いたスクリーニング方法
  15. 特開2012－125194 腫瘍血管新生制御遺伝子
  16. 特開2011－217651 小型水生動物実験飼育水槽システム
  17. 特開2011－148794 中枢神経系組織標識用組成物、中枢神経系組織の標識方法、及び中枢神経系組織標識用組成物を用いたスクリーニング方法（PMT出願）
  18. 特開2011－148793 経鼻中枢神経系組織標識用組成物、経鼻中枢神経系組織標識用組成物を用いた標識方法及びスクリーニング方法
  19. 特開2011－055755 MXD3遺伝子の発現阻害による肥満の抑制
  20. 特開2010－276559 試料観察システム及び試料観察方法
  21. 特開2010－273655 細胞保持方法、細胞試験方法及び細胞処理装置
  22. 特開2010－273654 物体保持用シート、試験方法及び物体処理装置
  23. 特開2010－169678 生物試料用標識剤並びに該標識剤を用いた標識方法及びスクリーニング方法
  24. 特開2010－169677 有毛細胞標識剤、及び該標識剤を用いた有毛細胞標識方法
  25. 特開2010－168369 眼内組織用標識組成物、眼内組織の標識方法及びスクリーニング方法
  26. 特開2010－148447 網膜組織染色組成物、網膜組織の染色方法
  27. 国際特許公開特開2009-148249 生体の保存方法、生体の試験方法、生体の生育方法、生体の 保持用シートおよび生体の処理装置
  28. 特開2009-038977 小型魚類機能評価システム
  29. 特開2008-193912 心不全治療薬のスクリーニング方法
  30. 特開2008-118882 トルサード・ド・ポアンツ型心室頻拍を呈するゼブラフィッシュ
  31. 特開2007-129982 心不全症状を呈するゼブラフィッシュ

Patent List (World) 
1. US. 2015/0139908, May. 21, 2015. Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method
2. US. 2014/0112869, Jan. 2, 2014. Central nervous system labelling composition for intranasal administration and labelling method and screening method using central nervous system labelling composition for intranasal administration
3. US. 2013/0280169, Jun. 19, 2013. Central nervous system tissue-labeling composition, method for labeling central nervous system tissue, and screening method using central nervous system tissue-labeling composition
4. US 2012/0207683 A1, Aug. 16, 2012. Evaluation probe for central nervous system permeability, evaluation method for central nervous system permeability, and screening method using an evaluation probe for central nervous system permeability
5. US. 2010/0304428, May. 26, 2010. Cell holding method, cell testing method and cell handling apparatus
6. US. 2010/0300547, May. 26, 2010. Object-holding sheet, test method and object-treating equipment
7. US. 2010/0302534, May. 26, 2010. Sample observation system and sample observation process
8. US 2009/8460639, Dec. 22, 2009. Probe for a hair cell, and labelling method for a hair cell using the probe for a hair cell.
9. US. 2010/0221831, Nov. 27, 2008. Living body holding method, living body test method, living body growing method, living body holding sheet, and living body processing device

ホーム

コメント

コメントの投稿

非公開コメント

最近追加した記事

6/10: 京都旅行1（3/27記事）
6/10: ヒトエグサ（3/23記事）
5/8: Editorial（3/11記事）
5/8: Published（2/21記事）
4/1: UVC（1/17記事）
4/1: コロナ禍（10/27記事）
4/1: コロナワクチン（7/4記事）
3/28: Published（7/18記事）
3/21: eLife（1/7記事）
3/21: mxd3（12/6記事）
3/21: グロビン（10/2記事）
3/21: Published（9/27記事）
3/21: ビーズバス（7/19記事）
8/13: HP掲載（7/15記事）

Twitter

カテゴリ